智通财经APP获悉，1月12日，医渡科技(02158)开盘后股价强势拉升，涨幅一度超过9%，截至发稿，涨7.45%，报6.35港元，成交额1.49亿港元。
消息面上，近日，由北京大学第一医院牵头，医渡科技参与共建的“多模态智能诊疗系统研发与转化应用北京市重点实验室”成功获批。该实验室将聚焦心肾代谢综合征的智能化诊疗攻关，是医渡科技持续深耕专科智能诊疗的又一个关键里程碑。作为实验室的核心共建方，医渡科技将大模型技术能力，深度注入实验室的研发链条，为智能诊疗的落地提供坚实底座。
全球AI医疗市场正迈入万亿级增长通道。据Grand View Research报告显示，2024年全球AI医疗市场规模约为266.5亿美元（约合人民币1861亿元），预计到2033年将飙升至约5055.9亿美元（约合人民币3.5万亿元），期间年复合增长率达38.8%。
东莞证券表示，随着国内科技巨头积极布局AI医疗赛道，有望快速推进我国医疗信息化和普惠化进程，并加速AI垂类应用场景落地，医疗或成为AI垂类应用场景的重要突破口。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.